These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2801787)

  • 21. Renal side-effects of cyclosporin A with special reference to autoimmune diseases.
    Mihatsch MJ; Thiel G; Ryffel B
    Br J Dermatol; 1990 Jun; 122 Suppl 36():101-15. PubMed ID: 2196077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal function in patients with autoimmune diseases treated with cyclosporine.
    von Graffenried B; Harrison WB
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):215-31. PubMed ID: 3839609
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effects of cyclosporine G and D treatment on experimental autoimmune uveoretinitis and kidney in rats].
    Kawashima H; Okumura A; Fujino Y; Tange T; Horiuchi D; Higashihara E; Mochizuki M
    Nippon Ganka Gakkai Zasshi; 1987 Oct; 91(10):940-50. PubMed ID: 3502061
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of ciclosporin on plasma renin activity, catecholamines and prostaglandins in patients with idiopathic uveitis.
    Deray G; Le Hoang P; Cacoub P; Hornych A; Legrand S; Aupetit B; Zogbi F; Landault C; Carayon A; Baumelou A
    Am J Nephrol; 1988; 8(4):298-304. PubMed ID: 3055993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney pathology in liver allograft recipients after long-term treatment with cyclosporin A.
    Dische FE; Neuberger J; Keating J; Parsons V; Calne RY; Williams R
    Lab Invest; 1988 Apr; 58(4):395-402. PubMed ID: 3282124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Side effects of cyclosporin following kidney transplantation and in patients with autoimmune diseases].
    von Graffenried B; Krupp P
    Internist (Berl); 1985 Sep; 26(9):542-8. PubMed ID: 3905674
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclosporine-induced renal morphologic and immunohistologic changes in patients with chronic uveitis.
    Andersen CB; Larsen S; Elmgreen J; Tvede N; Andersen V
    APMIS; 1991 Jun; 99(6):576-82. PubMed ID: 2054176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
    Yagisawa T; Omoto K; Shimizu T; Ishida H; Tanabe K
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():51-7. PubMed ID: 26031587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for the development of chronic cyclosporine-nephrotoxicity.
    Mihatsch MJ; Steiner K; Abeywickrama KH; Landmann J; Thiel G
    Clin Nephrol; 1988 Apr; 29(4):165-75. PubMed ID: 3284669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal interstitial fibrosis in children treated with FK506 for nephrotic syndrome.
    Morgan C; Sis B; Pinsk M; Yiu V
    Nephrol Dial Transplant; 2011 Sep; 26(9):2860-5. PubMed ID: 21303962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal lesions in ciclosporin A-treated kidney transplant patients.
    Banfi G; Imbasciati E; Fogazzi GB; Tarantino A
    Appl Pathol; 1987; 5(2):95-100. PubMed ID: 3307851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cyclosporin treatment in uveitis].
    Quentin CD; Vogel M
    Klin Monbl Augenheilkd; 1986 Mar; 188(3):248-50. PubMed ID: 3713099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined steroid-cyclosporin treatment of chronic autoimmune diseases. Clinical results and assessment of nephrotoxicity by renal biopsy.
    Miescher PA; Favre H; Chatelanat F; Mihatsch MJ
    Klin Wochenschr; 1987 Aug; 65(15):727-36. PubMed ID: 3626435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ciclosporin on cardiac output and regional blood flow in rats: ciclosporin-induced nephropathy and its prevention with calcium channel blocker.
    Kishimoto T; Tsujino T; Nakatani T; Kim T; Ohyama A; Sakamoto W; Yoshimura R; Maekawa T; Maekawa M
    Nephron; 1992; 61(2):204-10. PubMed ID: 1630547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM; Kobashigawa J; Klintmalm G
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does calcium antagonist improve established early ciclosporin nephrotoxicity after renal transplantation?
    Morales JM; Andres A; Montoyo C; Ortuño B; Rodicio JL
    Nephron; 1991; 57(2):227-9. PubMed ID: 2020352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic nephrotoxicity complicating cyclosporine treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
    Kolkin S; Nahman NS; Mendell JR
    Neurology; 1987 Jan; 37(1):147-9. PubMed ID: 3796829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-2-microglobulin for differentiation between ciclosporin A nephrotoxicity and graft rejection in renal transplant recipients.
    Prischl F; Gremmel F; Schwabe M; Schindler J; Balcke P; Kopsa H; Pinter G; Schwarzmeier J; Zazgornik J
    Nephron; 1989; 51(3):330-7. PubMed ID: 2645532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic irreversible nephrotoxicity from cyclosporin A.
    Rao KV; Crosson JT; Kjellstrand CM
    Nephron; 1985; 41(1):75-7. PubMed ID: 3897887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.